Real-Time Decision Support for Improving Intraoperative Cerebral Perfusion Pressure
Sponsor: University of Michigan
Listed as NCT03285971, this EARLY_PHASE1 trial focuses on Cerebral Hypoperfusion and remains completed. Sponsored by University of Michigan, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2022 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
Jan 2022 — Nov 2022 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2021 — Jan 2022 [monthly]
Recruiting EARLY_PHASE1
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2020 — Nov 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2019 — Jun 2020 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2018 — Jun 2019 [monthly]
Recruiting EARLY_PHASE1
-
Oct 2017 — Jun 2018 [monthly]
Recruiting EARLY_PHASE1
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .